BCDA vs JCI · $14.4M cap vs P/E 44, rev $23.60B
Biocardia Inc (BCDA) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Biocardia Inc (BCDA) is a biotechnology company listed on NASDAQ.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
BCDA does not have a complete income-statement cache yet.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
BCDA currently screens at market cap $14.4M. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the BCDA and JCI stock pages for the full models.
Not investment advice.